Home
Conditions
Advanced Malignant Solid Neoplasm

Clinical trial condition

Advanced Malignant Solid Neoplasm

Explore clinical trials studying Advanced Malignant Solid Neoplasm. Study availability and eligibility vary by location and protocol.

133 public trials 26 recruiting studies

Refine in advanced search Browse all conditions

Advanced Malignant Solid Neoplasm trial results

Active, Not Recruiting

Riluzole and Sorafenib Tosylate in Treating Patients With Advanced Solid Tumors or Melanoma

NCT01303341

Conditions: Advanced Malignant Solid Neoplasm, Melanoma, Neoplasms, +17 more
Locations: Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States

View Trial Details

Active, Not Recruiting

Akt Inhibitor MK2206 and Hydroxychloroquine in Treating Patients With Advanced Solid Tumors, Melanoma, Prostate or Kidney Cancer

NCT01480154

Conditions: Adenocarcinoma, Advanced Malignant Solid Neoplasm, Carcinoma, +37 more
Locations: Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States

View Trial Details

Active, Not Recruiting

Veliparib and Dinaciclib in Treating Patients With Advanced Solid Tumors

NCT01434316

Conditions: Advanced Malignant Solid Neoplasm
Locations: Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Active, Not Recruiting

Testing Crizotinib as Potentially Targeted Treatment in Cancers With MET Genetic Changes (MATCH - Subprotocol C1)

NCT06357975

Conditions: Advanced Lymphoma, Advanced Malignant Solid Neoplasm, Blood Protein Disorders, +19 more
Locations: ECOG-ACRIN Cancer Research Group Philadelphia, Pennsylvania, United States

View Trial Details

Active, Not Recruiting

Mindfulness-Based Intervention for Latino Cancer Patients and Their Caregivers

NCT04870788

Conditions: Advanced Malignant Solid Neoplasm
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, Not Recruiting

Dasatinib, Temsirolimus, and Cyclophosphamide in Treating Patients With Advanced, Recurrent, or Refractory Solid Tumors

NCT02389309

Conditions: Advanced Malignant Solid Neoplasm, Brain Diseases, Brain Neoplasms, +9 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, Not Recruiting

Testing the Biological Effects of DS-8201a on Patients With Advanced Cancer

NCT04294628

Conditions: Advanced Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm, Neoplasm Metastasis, +6 more
Locations: National Cancer Institute Developmental Therapeutics Clinic Bethesda, Maryland, United States

National Institutes of Health Clinical Center Bethesda, Maryland, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

NYP/Weill Cornell Medical Center New York, United States

View Trial Details

Active, Not Recruiting

Open Labeled Placebo in Reducing Cancer Related Fatigue in Patients With Advanced Cancer

NCT03927885

Conditions: Advanced Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm, Neoplasm Metastasis, +5 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, Not Recruiting

Frequency of Cachexia in Ambulatory Cancer Patients and Psychological Burden in Patients and Their Primary Caregivers

NCT04090619

Conditions: Advanced Malignant Solid Neoplasm, Blood Protein Disorders, Cardiovascular Diseases, +26 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, Not Recruiting

Niraparib, Temozolomide and Atezolizumab in Treating Patients With Advanced Solid Tumors and Extensive-Stage Small Cell Lung Cancer With a Complete or Partial Response to Platinum-Based First-Line Chemotherapy

NCT03830918

Conditions: Advanced Malignant Solid Neoplasm, Bronchial Neoplasms, Carcinoma, Bronchogenic, +16 more
Locations: UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States

View Trial Details

Advanced Malignant Solid Neoplasm

Advanced Malignant Solid Neoplasm trial results

Related conditions